These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 1742081)

  • 1. Soluble CD4-PE40 is cytotoxic for a transfected mammalian cell line stably expressing the envelope protein of human immunodeficiency virus (HIV-1), and cytotoxicity is variably inhibited by the sera of HIV-1-infected patients.
    Pitts TW; Bohanon MJ; Leach MF; McQuade TJ; Marschke CK; Merritt JA; Wierenga W; Nicholas JA
    AIDS Res Hum Retroviruses; 1991 Sep; 7(9):741-50. PubMed ID: 1742081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of recombinant soluble CD4 Pseudomonas exotoxin, a novel immunotoxin, for treatment of persons infected with human immunodeficiency virus.
    Davey RT; Boenning CM; Herpin BR; Batts DH; Metcalf JA; Wathen L; Cox SR; Polis MA; Kovacs JA; Falloon J
    J Infect Dis; 1994 Nov; 170(5):1180-8. PubMed ID: 7963711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interdomain interactions in the chimeric protein toxin sCD4(178)-PE40: a differential scanning calorimetry (DSC) study.
    Davio SR; Kienle KM; Collins BE
    Pharm Res; 1995 May; 12(5):642-8. PubMed ID: 7479546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of CD4-Pseudomonas exotoxin against cells expressing diverse forms of the HIV and SIV envelope glycoproteins.
    Ashorn P; Moss B; Berger EA
    J Acquir Immune Defic Syndr (1988); 1992; 5(1):70-7. PubMed ID: 1738090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.
    Moore JP; McKeating JA; Jones IM; Stephens PE; Clements G; Thomson S; Weiss RA
    AIDS; 1990 Apr; 4(4):307-15. PubMed ID: 2190605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
    Bower JF; Green TD; Ross TM
    Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant CD4-Pseudomonas exotoxin hybrid protein displays HIV-specific cytotoxicity without affecting MHC class II-dependent functions.
    Berger EA; Chaudhary VK; Clouse KA; Jaraquemada D; Nicholas JA; Rubino KL; Fitzgerald DJ; Pastan I; Moss B
    AIDS Res Hum Retroviruses; 1990 Jun; 6(6):795-804. PubMed ID: 2114147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a soluble CD4 and CD4-Pseudomonas exotoxin A chimeric protein on human peripheral blood lymphocytes: lymphocyte activation and anti-HIV activity in vitro.
    Rubino KL; Tarpley WG; Nicholas JA
    Antiviral Res; 1991 Oct; 16(3):267-79. PubMed ID: 1805685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface expression of the HIV-1 envelope proteins in env gene-transfected CD4-positive human T cell clones: characterization and killing by an antibody-dependent cellular cytotoxic mechanism.
    Ahmad A; Yao XA; Tanner JE; Cohen E; Menezes J
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):789-98. PubMed ID: 7912729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.
    Dey B; Del Castillo CS; Berger EA
    J Virol; 2003 Mar; 77(5):2859-65. PubMed ID: 12584309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary HIV-1 isolates refractory to neutralization by soluble CD4 are potently inhibited by CD4-Pseudomonas exotoxin.
    Kennedy PE; Moss B; Berger EA
    Virology; 1993 Jan; 192(1):375-9. PubMed ID: 8517027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.
    Moore JP; McKeating JA; Norton WA; Sattentau QJ
    J Virol; 1991 Mar; 65(3):1133-40. PubMed ID: 1995942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120.
    Salzwedel K; Smith ED; Dey B; Berger EA
    J Virol; 2000 Jan; 74(1):326-33. PubMed ID: 10590121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a defect of antibody-dependent cellular cytotoxic (ADCC) effector function and anti-HIV gp120/41-specific ADCC-mediating antibody titres in HIV-infected individuals.
    Ahmad A; Morisset R; Thomas R; Menezes J
    J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):428-37. PubMed ID: 7908983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 gp120/160 expressing transfected cell clones to evaluate the antibody-dependent cellular cytotoxicity (ADCC) during the course of HIV-1 infection.
    Merzouki A; Patel P; Cassol S; O'Shaughnessy M; Gill J; Arella M
    J Virol Methods; 1994 Jun; 48(1):9-21. PubMed ID: 7962264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor.
    Brighty DW; Rosenberg M; Chen IS; Ivey-Hoyle M
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7802-5. PubMed ID: 1909031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale immunoaffinity purification of recombinant soluble human antigen CD4 from Escherichia coli cells.
    Wells PA; Beiderman B; Garlick RL; Lyle SB; Martin JP; Herberg JT; Meyer HF; Henderson SL; Eckenrode FM
    Biotechnol Appl Biochem; 1993 Dec; 18(3):341-57. PubMed ID: 8297511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of short-term CD4-PE40 infusions to reduce virus load in human immunodeficiency virus-infected persons.
    Ramachandran RV; Katzenstein DA; Wood R; Batts DH; Merigan TC
    J Infect Dis; 1994 Oct; 170(4):1009-13. PubMed ID: 7930696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses.
    Berger EA; Clouse KA; Chaudhary VK; Chakrabarti S; FitzGerald DJ; Pastan I; Moss B
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9539-43. PubMed ID: 2480605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of infectious human immunodeficiency virus from human T-cell cultures by synergistic action of CD4-Pseudomonas exotoxin and reverse transcriptase inhibitors.
    Ashorn P; Moss B; Weinstein JN; Chaudhary VK; FitzGerald DJ; Pastan I; Berger EA
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8889-93. PubMed ID: 1701055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.